Works matching IS 13406868 AND DT 2013 AND VI 20 AND IP 2


Results: 13
    1
    2
    3
    4

    Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B.

    Published in:
    Breast Cancer (13406868), 2013, v. 20, n. 2, p. 131, doi. 10.1007/s12282-011-0316-z
    By:
    • Hayashi, Hidetoshi;
    • Tsurutani, Junji;
    • Satoh, Taro;
    • Masuda, Norikazu;
    • Okamoto, Wataru;
    • Morinaga, Ryotaro;
    • Terashima, Masaaki;
    • Miyazaki, Masaki;
    • Okamoto, Isamu;
    • Nishida, Yukihiro;
    • Tominaga, Shusei;
    • Tokunaga, Yukihiko;
    • Yamaguchi, Masahide;
    • Sakamoto, Junichi;
    • Nakayama, Takahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13